Cell biology and pathophysiology of α-synuclein

J Burré, M Sharma, TC Südhof - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
α-Synuclein is an abundant neuronal protein that is highly enriched in presynaptic nerve
terminals. Genetics and neuropathology studies link α-synuclein to Parkinson's disease (PD) …

How is alpha‐synuclein cleared from the cell?

L Stefanis, E Emmanouilidou… - Journal of …, 2019 - Wiley Online Library
The levels and conformers of alpha‐synuclein are critical in the pathogenesis of Parkinson's
Disease and related synucleinopathies. Homeostatic mechanisms in protein degradation …

Lysosomal exocytosis releases pathogenic α-synuclein species from neurons in synucleinopathy models

YX **e, NN Naseri, J Fels, P Kharel, Y Na… - Nature …, 2022 - nature.com
Considerable evidence supports the release of pathogenic aggregates of the neuronal
protein α-Synuclein (αSyn) into the extracellular space. While this release is proposed to …

Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival

E Emmanouilidou, K Melachroinou… - Journal of …, 2010 - jneurosci.org
α-Synuclein is central in Parkinson's disease pathogenesis. Although initially α-synuclein
was considered a purely intracellular protein, recent data suggest that it can be detected in …

Matrix metalloproteinases in the brain and blood–brain barrier: versatile breakers and makers

RG Rempe, AMS Hartz, B Bauer - Journal of Cerebral Blood …, 2016 - journals.sagepub.com
Matrix metalloproteinases are versatile endopeptidases with many different functions in the
body in health and disease. In the brain, matrix metalloproteinases are critical for tissue …

Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: Pathophysiological and therapeutic perspectives

T Behl, G Kaur, A Sehgal, S Bhardwaj, S Singh… - International Journal of …, 2021 - mdpi.com
Neurodegeneration is the pathological condition, in which the nervous system or neuron
loses its structure, function, or both, leading to progressive degeneration or the death of …

Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein

W Wang, LTT Nguyen, C Burlak, F Chegini… - Proceedings of the …, 2016 - pnas.org
The aggregation of α-synuclein (aSyn) leading to the formation of Lewy bodies is the
defining pathological hallmark of Parkinson's disease (PD). Rare familial PD-associated …

Microglia response during Parkinson's disease: alpha-synuclein intervention

SA Ferreira, M Romero-Ramos - Frontiers in cellular neuroscience, 2018 - frontiersin.org
The discovery of the central role played by the protein alpha-synuclein in Parkinson's
disease and other Lewy body brain disorders has had a great relevance in the …

[HTML][HTML] The emerging role of α-synuclein truncation in aggregation and disease

ZA Sorrentino, BI Giasson - Journal of Biological Chemistry, 2020 - Elsevier
α-Synuclein (αsyn) is an abundant brain neuronal protein that can misfold and polymerize to
form toxic fibrils coalescing into pathologic inclusions in neurodegenerative diseases …

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

D Games, E Valera, B Spencer, E Rockenstein… - Journal of …, 2014 - jneurosci.org
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are common
neurodegenerative disorders of the aging population, characterized by progressive and …